Anand Rathi Share and Stock Brokers Limited Schedules Board Meeting for April 14, 2026 to Approve Q4FY26 Results

1 min read     Updated on 09 Apr 2026, 06:38 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Anand Rathi Share and Stock Brokers Limited has scheduled its board meeting for April 14, 2026, to approve standalone and consolidated audited financial results for Q4FY26 and the full financial year ended March 31, 2026. The board will also consider final dividend recommendations for FY 2025-26, subject to shareholder approval at the 35th Annual General Meeting. The company's trading window, closed since April 01, 2026, will reopen 48 hours after the financial results declaration.

powered bylight_fuzz_icon
37285733

*this image is generated using AI for illustrative purposes only.

Anand Rathi Share and Stock Brokers Limited has informed stock exchanges about its upcoming board meeting scheduled for April 14, 2026, where directors will review and approve the company's financial performance for the fourth quarter and full financial year ended March 31, 2026.

Board Meeting Agenda

The board meeting will address several key matters as outlined in the company's regulatory filing dated April 09, 2026. The primary agenda items demonstrate the company's commitment to transparent financial reporting and shareholder value creation.

Agenda Item Details
Standalone Results Consider and approve audited financial results for Q4 and FY ended March 31, 2026
Consolidated Results Consider and approve consolidated audited financial results for Q4 and FY ended March 31, 2026
Dividend Recommendation Consider final dividend recommendation for FY 2025-26
AGM Reference Subject to approval at 35th Annual General Meeting

Regulatory Compliance and Trading Window

In accordance with SEBI regulations, the company has implemented appropriate measures regarding insider trading restrictions. The trading window for designated persons and their immediate relatives was closed from April 01, 2026, ensuring compliance with market integrity requirements.

The trading window will reopen after 48 hours from the declaration of the financial results, following the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Regulatory Framework

The board meeting notification has been issued pursuant to Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework ensures that all material information is disclosed to investors and market participants in a timely and transparent manner.

The company has also uploaded this information on its official website at anandrathi.com/investors, ensuring broader accessibility for stakeholders and maintaining compliance with disclosure requirements.

Corporate Governance

The meeting reflects the company's adherence to corporate governance standards, with the board addressing both financial performance review and potential shareholder returns through dividend considerations. The final dividend recommendation, if approved by the board, will require subsequent approval from shareholders at the company's 35th Annual General Meeting.

How might Anand Rathi's Q4 FY2026 results compare to industry peers given the current market conditions in the brokerage sector?

What impact could the proposed dividend recommendation have on Anand Rathi's stock price and investor sentiment in the near term?

Will Anand Rathi's financial performance influence its expansion plans or technology investments for FY2027?

like17
dislike

CARE Ratings Upgrades Anand Rathi Share and Stock Brokers Credit Ratings Following ₹745 Crore Equity Infusion

3 min read     Updated on 09 Apr 2026, 05:53 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

CARE Ratings Limited upgraded Anand Rathi Share and Stock Brokers Limited's credit ratings across all debt instruments, including bank facilities of ₹1,400 crore upgraded to CARE A; Stable/CARE A1+, market linked debentures of ₹50 crore to CARE PP-MLD A; Stable, and commercial paper of ₹200 crore to CARE A1+. The upgrades reflect the ₹745 crore equity infusion through the company's September 2025 IPO, which improved leverage metrics from 2.59x to 0.90x and increased tangible net worth to ₹1,335 crore. The ratings are supported by experienced management, diversified revenue streams, and strong liquidity position, though constrained by modest market scale and competitive intensity in the broking segment.

powered bylight_fuzz_icon
37282982

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has announced comprehensive credit rating upgrades for Anand Rathi Share and Stock Brokers Limited (ARSSBL), reflecting the company's strengthened financial position following a substantial equity infusion. The rating agency upgraded all debt instruments and bank facilities, citing improved financial flexibility and enhanced leverage metrics.

Rating Upgrades Across All Instruments

The credit rating upgrades span across ARSSBL's entire portfolio of debt instruments and banking facilities:

Instrument Type Amount New Rating Previous Rating
Long-term/Short-term Bank Facilities ₹1,400 crore CARE A; Stable/CARE A1+ CARE A-; Stable/CARE A1
Market Linked Debentures ₹50 crore CARE PP-MLD A; Stable CARE PP MLD A-; Stable
Commercial Paper ₹200 crore CARE A1+ CARE A1

The upgrades were communicated through CARE Ratings' letter dated April 08, 2026, and subsequently disclosed by ARSSBL to stock exchanges under Regulation 30 of SEBI listing requirements.

Key Drivers Behind Rating Enhancement

The rating upgrade primarily reflects the significant equity infusion of ₹745 crore raised through ARSSBL's initial public offering in September 2025. This capital injection has substantially improved the company's financial flexibility and is expected to support growth in the margin trading facility (MTF) and distribution segments while improving leverage metrics over the medium term.

ARSSBL's tangible net worth increased dramatically to ₹1,335 crore as on December 31, 2025, from ₹495 crore as on March 31, 2025. Consequently, overall gearing moderated significantly from 2.59x in FY25 to 0.90x in 9MFY26, while fund-based gearing improved from 1.83x to 0.59x during the same period.

Financial Performance and Business Diversification

The company demonstrated strong financial performance in FY25, with total income growing 23.73% to ₹845 crore, driven by higher interest income and brokerage revenue. Profit after tax stood at ₹104 crore, translating to a PAT margin of 12.29%, reflecting an improvement of 78 basis points year-on-year.

ARSSBL has successfully diversified its revenue profile, reducing dependence on volatile broking income. While brokerage contributed approximately 80% of total income in FY17, its share declined to 52.39% in FY25 and 44.68% in 9MFY26. The balance is now driven by interest income, primarily from MTF operations, and distribution income.

Financial Metrics March 31, 2024 March 31, 2025 9MFY26
Total Income ₹683 crore ₹845 crore ₹679 crore
Profit After Tax ₹79 crore ₹104 crore ₹90 crore
Tangible Net Worth ₹385 crore ₹495 crore ₹1,335 crore
MTF Loan Book ₹617 crore ₹686 crore ₹1,232 crore

Rating Strengths and Constraints

CARE Ratings highlighted several key strengths supporting the upgraded ratings:

  • Experienced management team led by co-founder and Managing Director Pradeep Gupta
  • Established presence in the broking industry with over three decades of experience
  • Strategic importance within the diversified Anand Rathi Group ecosystem
  • Stable earnings profile with diversified income streams
  • Strong liquidity position with overall liquidity of ₹3,197 crore as on December 31, 2025

However, the ratings remain constrained by modest scale of broking operations relative to larger industry peers, inherent risks associated with capital market-linked businesses, competitive intensity in the core broking segment, and the evolving regulatory landscape affecting the sector.

Market Position and Growth Outlook

ARSSBL maintains a market share of 0.25% across both cash and derivatives segments in FY25, with relatively higher presence in the cash segment at 0.88%. The company's MTF book has emerged as a key growth driver, scaling from ₹305 crore as on March 31, 2022, to ₹1,232 crore as on December 31, 2025.

The asset under distribution (AUD) has grown from ₹2,772 crore as on March 31, 2022, to ₹8,369 crore as on December 31, 2025, with mutual funds comprising the largest component. CARE Ratings has assigned a stable outlook, expecting ARSSBL to continue demonstrating stable business profile with timely support from the parent company given its strategic importance and shared brand name.

How will ARSSBL utilize the ₹745 crore IPO proceeds to compete against larger broking peers and expand its modest 0.25% market share?

What impact could evolving regulatory changes in the capital markets sector have on ARSSBL's growth strategy and margin trading facility expansion?

Will ARSSBL's improved credit ratings enable the company to secure more competitive borrowing rates for funding its rapidly growing MTF loan book?

like15
dislike

More News on Anand Rathi Share & Stock Brokers